GCL
MRTX

Glazer Capital LLC’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Glazer Capital LLC’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,297
Closed -$487K – 161
2023
Q4 		$487K Buy
+8,297
New +$487K 0.05% 117